Literature DB >> 141798

Therapeutic studies with BCG, cyclophosphamide and surgery alone and in combination on the autochthonous mammary carcinoma of the rat.

E Storch, H H Fiebig, D Schmähl.   

Abstract

In a randomized study the effects of BCG, cyclophosphamide and surgery alone and in combination on the mammary carcinoma (induced by 7,12-dimethylbenz(a)anthracene) of the rat were investigated. Surgical excision of the tumours increased the survival time. Cyclophosphamide retarded growth of tumours and delayed the appearance of relapses compared to surgery. A single, intravenous injection of BCG (10(7) viable organisms) showed no statistically significant retardation of tumours. Immunotherapy with BCG could not increase the effectiveness of cyclophosphamide or surgery or their combination.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 141798     DOI: 10.1007/bf02571687

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  15 in total

1.  [Comparative investigation of the chemotherapeutic action of N-oxide-mustard gas and other alkylating compounds in rat tumors].

Authors:  P DANNEBERG; H DRUCKREY; K KAISER; H W LO; R MECKE; H A NIEPER; D SCHMAHL
Journal:  Arzneimittelforschung       Date:  1956-09

2.  Introduction: animal models of immunotherapy of cancer.

Authors:  H J Rapp
Journal:  Natl Cancer Inst Monogr       Date:  1973-12

Review 3.  Active immunotherapy.

Authors:  G Mathé
Journal:  Adv Cancer Res       Date:  1971       Impact factor: 6.242

4.  Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma.

Authors:  A E Bogden; H J Esber; D J Taylor; J H Gray
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

5.  Facilitation of rat mammary tumour growth by BCG.

Authors:  W F Piessens; F L Lachapelle; N Legros; J C Heuson
Journal:  Nature       Date:  1970-12-19       Impact factor: 49.962

6.  [Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)].

Authors:  H H Fiebig; D Schmähl
Journal:  Klin Wochenschr       Date:  1977-05-01

7.  An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.

Authors:  G Mathé; M Kamel; M Dezfulian; O Halle-Pannenko; C Bourut
Journal:  Cancer Res       Date:  1973-09       Impact factor: 12.701

8.  [Studies in rats on immunosuppressive properties of cytostatics with special consideration of carcinogenic effect].

Authors:  H R Scherf; C Krüger; C Karsten
Journal:  Arzneimittelforschung       Date:  1970-10

Review 9.  Immunological factors which influence response to immunotherapy in malignant melanoma.

Authors:  D Morton; F R Eilber; R A Malmgren; W C Wood
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

10.  Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.

Authors:  G Mathé; P Pouillart; F Lapeyraque
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

View more
  2 in total

1.  Chemotherapy studies in autochthonous rat tumors: hepatomas.

Authors:  M Habs; G Habs; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-11-18

2.  Chemotherapy studies in autochthonous rat tumors intestinal cancer.

Authors:  F Sych; M Habs; D Schmähl
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.